FDA clears AI-powered ‘thermometer of the future’ with ECG sensors
Withings, a French medtech company, has received U.S. Food and Drug Administration (FDA) clearance for BeamO, a new artificial intelligence (AI)-enabled device it describes as the “thermometer of the future.” BeamO includes electrocardiogram sensors, a stethoscope and a thermometer, providing users with a single check-up tool that evaluates a body temperature, cardiac health and pulmonary health in less than one minute—all from the comfort of home.
“BeamO is equipped with highly innovative sensors, meeting the challenge of miniaturization to bring together so many functionalities in such a small device,” Xavier Debreuil, product research director at Withings, said in a statement. “These sensors record the heart's electrical activity as well as measure infrared light to interpret body temperature. On the other hand, they capture acoustic waves to study the activity of the heart and lungs. All the data is analyzed by artificial intelligence algorithms to identify anomalies.”
“BeamO brings access to key vital signs, typically measured during medical consultations, into everyday life,” added Eric Carreel, founder and president of Withings. “All this new data on the heart, lungs, and temperature provides an overview of the state of each user's health. This data promotes a much more precise and reliable diagnosis, and it marks a revolution in telemedicine, transforming it into a true medical consultation by integrating the data collection component.”
With FDA clearance now secured, BeamO is officially for sale in the United States. The price is $249.95.
By early 2026, the new-look thermometer will be available on Amazon and a variety of other retail partners.
A closer look at the features available on BeamO
BeamO was developed to provide multiple at-home measurements in seconds.
The newly cleared device features two stainless steel electrodes, for instance, that can perform a one-lead ECG; the person simply grips it to trigger a recording. A piezoelectric sensor for capturing acoustic soundwaves in the chest or back is also included. This was designed to help users obtain heart and lung evaluations, and Withings developed guided tutorials to make this step as easy as possible.
Body temperature, meanwhile, is evaluated via a contactless analysis of the temporal artery.
Another central component of this technology is HealthLink, a feature found on the Withings smartphone app that helps users generate detailed health reports for their own clinicians. Users with a Withings+ subscription can then use these reports to obtain a detailed cardiac assessment performed by a cardiologist.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.